Philipp du Cros

Treatment Outcomes for Serious Infections Caused by Methicillin‐Resistant<i>Staphylococcus aureus</i>with Reduced Vancomycin Susceptibility

Benjamin P. Howden, Peter Ward, Patrick G. P. Charles et al. · Clinical Infectious Diseases · 2004 · 483 citations

Antimicrobial Chemotherapy, Reduced Vancomycin Susceptibility, Antibiotic Resistance +16

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · New England Journal of Medicine · 2022 · 318 citations · Full text

A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays

Adam Penn‐Nicholson, Sivaramakrishnan N. Gomathi, César Ugarte‐Gil et al. · European Respiratory Journal · 2021 · 108 citations · Full text

Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

S.K. Abidi, Jay Achar, M.M. Assao Neino et al. · European Respiratory Journal · 2019 · 87 citations · Full text

Principles for designing future regimens for multidrug-resistant tuberculosis

Grania Brigden, Bern-Thomas Nyang’wa, Philipp du Cros et al. · Bulletin of the World Health Organization · 2013 · 80 citations · Full text